These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6873182)

  • 1. On the mechanism of action of amezinium methylsulphate on the dog saphenous vein.
    Araújo D; Caramona MM; Osswald W
    Eur J Pharmacol; 1983 Jun; 90(2-3):203-14. PubMed ID: 6873182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of MAO A and MAO B on the inactivation of noradrenaline in the saphenous vein of the dog.
    Caramona MM; Araújo D; Brandão F
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):401-6. PubMed ID: 3921856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a monoamine oxidase A inhibitor, FLA 668 (+) on the adrenergic mechanisms of the dog saphenous vein.
    Caramona MM; Esplugues JV; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):181-5. PubMed ID: 2935741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of oxidative deamination in the metabolism of exogenous noradrenaline by the normal and chemically denervated human uterine artery.
    Branco D; Caramona M; Martel F; de Almeida JA; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):286-93. PubMed ID: 1407015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deamination of released 3H-noradrenaline in the canine saphenous vein.
    Verbeuren TJ; Vanhoutte PM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):148-57. PubMed ID: 7063044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 2-adrenoceptor blockade prevents cardiac glycoside-evoked neurotransmitter release from sympathetic nerves in dog saphenous vein.
    Powis DA
    Br J Pharmacol; 1987 Sep; 92(1):213-20. PubMed ID: 2889493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.
    Caramona MM; Osswald W
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):396-400. PubMed ID: 3921855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disposition of 3H-(--)noradrenaline in the perfused cat and rabbit heart.
    Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):71-82. PubMed ID: 7329455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.
    Lenke D; Gries J; Kretzschmar R
    Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of monoamine oxidase activity on the release of noradrenaline by tyramine.
    Brandão F; Araújo D; Monteriro JG
    J Pharm Pharmacol; 1989 Oct; 41(10):729-32. PubMed ID: 2575157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of adrenergic neurotransmission in isolated veins of the dog by potassium ions.
    Lorenz RR; Vanhoutte PM
    J Physiol; 1975 Mar; 246(2):479-500. PubMed ID: 167162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of S-11701 on accumulation, release and metabolism of norepinephrine in isolated canine saphenous veins.
    Guo HY; Lorenz RR; Verbeuren TJ; Vanhoutte PM
    Gen Pharmacol; 1992 Nov; 23(6):1079-85. PubMed ID: 1487118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of acetylstrophanthidin and ouabain on the sympathetic adrenergic neuroeffector junction in canine vascular smooth muscle.
    Lorenz RR; Powis DA; Vanhoutte PM; Shepherd JT
    Circ Res; 1980 Dec; 47(6):845-54. PubMed ID: 7438335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate production.
    Hicks PE; Barras M; Herman G; Mauduit P; Armstrong JM; Rossignol B
    Br J Pharmacol; 1991 Jan; 102(1):151-61. PubMed ID: 1675142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.
    Bryan-Lluka LJ; Seers H; Sharpe I
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):536-44. PubMed ID: 8740147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple actions of cocaine on neuromuscular transmission and smooth muscle cells of the guinea-pig mesenteric artery.
    Kuriyama H; Suyama A
    J Physiol; 1983 Apr; 337():631-54. PubMed ID: 6308237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nifedipine on potassium-induced contraction and noradrenaline release in cerebral and extracranial arteries from rabbit.
    Högestätt ED; Andersson KE; Edvinsson L
    Acta Physiol Scand; 1982 Feb; 114(2):283-96. PubMed ID: 6127868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsuitability of the 86Rb+ uptake method for estimation of (Na+ + K+)-ATPase activity in innervated tissues.
    Powis DA; Madsen GM
    Biochim Biophys Acta; 1986 Oct; 861(2):251-8. PubMed ID: 3019401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norepinephrine metabolism in canine saphenous vein: prevalence of glycol metabolites.
    Muldoon SM; Vanhoutte PM; Tyce GM
    Am J Physiol; 1978 Mar; 234(3):H235-43. PubMed ID: 629360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline.
    Langeloh A; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):611-20. PubMed ID: 3444478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.